HUMANIZED ANTI-IL-20 ANTIBODY AND USES THEREOF

Ming-Shi Chang

HUMANIZED ANTI-IL-20 ANTIBODY AND USES THEREOF

貢獻的翻譯標題: HUMANIZED ANTI-IL-20 ANTIBODY AND USES THEREOF

Ming-Shi Chang (Inventor)

生物化學暨分子生物學研究所

研究成果: Patent

摘要

The present disclosure provides humanized antibodies specific to human interleukin 20 (IL-20) and uses thereof in treating diseases associated with the IL-20 signaling pathway, e.g., osteoporosis, inflammatory disease (e.g., rheumatoid arthritis), cancer, stroke, and renal failure.

貢獻的翻譯標題	HUMANIZED ANTI-IL-20 ANTIBODY AND USES THEREOF
原文	English
專利號	8597647
出版狀態	Published - 1800

UN SDG

此研究成果有助於以下永續發展目標

引用此

@misc{57febb47872746e6a56ed676c3742e1b,

title = "HUMANIZED ANTI-IL-20 ANTIBODY AND USES THEREOF",

abstract = "The present disclosure provides humanized antibodies specific to human interleukin 20 (IL-20) and uses thereof in treating diseases associated with the IL-20 signaling pathway, e.g., osteoporosis, inflammatory disease (e.g., rheumatoid arthritis), cancer, stroke, and renal failure.",

author = "Ming-Shi Chang",

year = "1800",

language = "English",

type = "Patent",

note = "8597647",

}

TY - PAT

T1 - HUMANIZED ANTI-IL-20 ANTIBODY AND USES THEREOF

AU - Chang, Ming-Shi

PY - 1800

Y1 - 1800

N2 - The present disclosure provides humanized antibodies specific to human interleukin 20 (IL-20) and uses thereof in treating diseases associated with the IL-20 signaling pathway, e.g., osteoporosis, inflammatory disease (e.g., rheumatoid arthritis), cancer, stroke, and renal failure.

AB - The present disclosure provides humanized antibodies specific to human interleukin 20 (IL-20) and uses thereof in treating diseases associated with the IL-20 signaling pathway, e.g., osteoporosis, inflammatory disease (e.g., rheumatoid arthritis), cancer, stroke, and renal failure.

M3 - Patent

M1 - 8597647

ER -

HUMANIZED ANTI-IL-20 ANTIBODY AND USES THEREOF

摘要

UN SDG

指紋

引用此